# Scenario run report

**LIVE run (real LLM; models: gemini-3.1-flash-lite)**

Totals: 42 pass, 5 fail, 12 need human review, 1 hypotheses not confirmed.

Statuses: `pass`/`fail` are objective checks; `review` needs a human; `differs` means the agent did not confirm one of our written gap hypotheses.

## Event 1: Baseline records arrive from Hospitals A and C
*2026-11-02T09:00*

Fatima (72) has kidney disease, type 2 diabetes, hypertension and atrial fibrillation, and a recorded penicillin allergy. Cardiology (A) uploads warfarin and ramipril; endocrinology (C) uploads metformin. No lab results are on file yet.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding MISSING:DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | no 'interaction' findings | none | none | **pass** |
| safety | no 'contraindication' findings | none | none | **pass** |
| safety | no 'lab-rule' findings | none | none | **pass** |
| consent | C_reads_A_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| policy | expectation for human review | Metformin cannot be assessed without eGFR: flag as uncertain, do not guess. | see agent output (conflicts, caveats, gaps) | **review** |
| audit | audit trail has 'grant_created' | present | present | **pass** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

## Event 2: Hospital B (Dubai) prescribes spironolactone
*2026-11-03T10:00*

Nephrology at Hospital B, in a different emirate, adds spironolactone. The patient already takes ramipril and has kidney disease. Neither hospital knows about the other's prescription unless data is shared.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-INT-002 present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-002:aldactone present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | severity of DEMO-INT-002 | high | high | **pass** |
| consent | A_reads_B_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| consent | B_reads_A_meds | {'allowed': True, 'reason_code': 'GRANTED'} | {'allowed': True, 'reason_code': 'GRANTED', 'escalate': False} | **pass** |
| policy | cites uae-health-ict-law-2019 ('confidentiality of health data') | cited | not cited | **fail** |
| policy | cites dha-health-info-sharing-2024 ('Consent must be obtained') | cited | not cited | **fail** |
| policy | cites doh-hie-policy-2020 ('Universal') | cited | ['doh-hie-policy-2020#0021'] | **pass** |
| policy | expectation for human review | Two emirate regimes apply (Abu Dhabi DoH and Dubai DHA); sharing here rests on the patient's grants. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CONSENT-REGIME-DIVERGENCE: hypothesis | Abu Dhabi's HIE policy (DoH 2020, s4.2) makes participation mandatory and authorizes sharing even when consent | not raised by the agent (hypothesis not confirmed) | **differs** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Policy agent** (2 searches, completed=True)
- *requirement:* In Abu Dhabi, the Department of Health (DOH) mandates universal participation of healthcare facilities in the ADHIE and requires facilities to obtain patient consent for sharing patient data via the ADHIE. [doh-hie-policy-2020#0021]
- *requirement:* Abu Dhabi healthcare facilities are required to incorporate specific consent language into their standard forms, stating that patients consent to the sharing of their newly-generated or past patient data via the ADHIE with the requesting facility and every other healthcare facility that sends or receives data via the ADHIE. [doh-hie-policy-2020#0022]
- *requirement:* In Abu Dhabi, if patient consent is unavailable for any reason, the DOH requires and authorizes healthcare facilities to share and receive patient data through the ADHIE pursuant to its regulatory authority. [doh-hie-policy-2020#0021, doh-hie-policy-2020#0022]
- *requirement:* In Dubai, healthcare facilities must include a clause within their general consent regarding sharing Protected Health Information (PHI) with NABIDH as per DHA mandates. [dha-consent-access-standard-2025#0017]
- *requirement:* In Dubai, consent is required for accessing PHI through Health Information Systems (HIS), and entities must record the consent (or refusal/withdrawal) with dates. [dha-consent-access-standard-2025#0015]
- *requirement:* Under UAE Federal Law No. (2) of 2019, consent is not required for sharing PHI in Electronic Medical Records (EMR), public health portals, and insurance systems. [dha-consent-access-standard-2025#0017]
- *requirement:* Under UAE Federal Law No. (2) of 2019 and Federal Law No. (45) of 2021, patient data must be kept confidential and not used for non-health purposes without written consent, except in specific cases such as judicial requests or legal claims. [dha-health-info-sharing-2024#0016]
- *gap (no_provision_found):* **Lack of explicit rules on cross-emirate HIE interoperability**: While the DHA policy acknowledges that sharing between entities in the UAE (not within the same organization) via HIE exchanges (Nabidh, Malaffi, Riayati) requires patient consent, the provided texts do not detail the technical or legal mechanism for how a consent grant in one emirate's exchange (e.g., NABIDH) is recognized or synchronized with another (e.g., Malaffi). [dha-health-info-sharing-2024#0015]
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): DoH Circular 2026/10: Mandatory On-boarding of Minimum Required Dataset with Malaffi, p.1 [doh-circular-2026-10-malaffi-onboarding#0001]; Standards for Health Information Consent and Access Control, Version 1 (2025), p.16 [dha-consent-access-standard-2025#0012]
- ⚠ Sent back once: only 1 search(es) before answering

## Event 3: Overdue lab results arrive three days late
*2026-11-06T16:00*

eGFR and potassium were taken on 3 Nov but only reach the system on 6 Nov. Until now the system had to treat both as unknown.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-LAB-002:aldactone present | present | present | **pass** |
| safety | finding DEMO-INT-002 present | present | present | **pass** |
| safety | finding MISSING:DEMO-LAB-001:glucophage absent | absent | absent | **pass** |
| safety | finding MISSING:DEMO-LAB-002:aldactone absent | absent | absent | **pass** |
| safety | severity of DEMO-LAB-001:glucophage | high | high | **pass** |
| safety | severity of DEMO-LAB-002:aldactone | high | high | **pass** |
| policy | expectation for human review | Earlier 'missing lab' uncertainty is resolved by the late result; the log must show both states. | see agent output (conflicts, caveats, gaps) | **review** |

## Event 4: Patient withdraws consent for Hospital B's data and opts out of NABIDH
*2026-11-07T11:00*

Fatima revokes every grant covering Hospital B's records and opts out of the Dubai exchange. From now on the platform must stop using Hospital B's data. Earlier sharing is already on record.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | finding DEMO-LAB-002:aldactone absent | absent | absent | **pass** |
| safety | limitation notice mentions HospitalB | present | present | **pass** |
| consent | A_reads_B_meds_direct | {'allowed': False, 'reason_code': 'REVOKED'} | {'allowed': False, 'reason_code': 'REVOKED', 'escalate': False} | **pass** |
| consent | A_reads_B_meds_exchange | {'allowed': False, 'reason_code': 'OPTED_OUT_OF_EXCHANGE'} | {'allowed': False, 'reason_code': 'OPTED_OUT_OF_EXCHANGE', 'escalate': False} | **pass** |
| policy | cites dha-consent-access-standard-2025 ('right to withdraw') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | cites dha-consent-access-standard-2025 ('retain such information') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | expectation for human review | The assessment is now incomplete by the patient's choice and must say so. | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | Information already shared may stay in recipients' records. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CONSENT-REGIME-DIVERGENCE: hypothesis | Abu Dhabi's HIE policy (DoH 2020, s4.2) makes participation mandatory and authorizes sharing even when consent | likely match: 'Applicability of Opt-Out to Abu Dhabi (Malaffi)' (no_provision_found) | **review** |
| audit | audit trail has 'grant_revoked' | present | present | **pass** |
| audit | audit trail has 'exchange_opt_out' | present | present | **pass** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Policy agent** (2 searches, completed=True)
- *requirement:* The withdrawal of consent does not affect any sharing of health information that occurred prior to the revocation. [dha-consent-access-standard-2025#0018]
- *requirement:* Entities that accessed or received health information via the Health Information System (HIS) prior to the revocation of consent and incorporated that information into their own records may retain it. [dha-consent-access-standard-2025#0018]
- *requirement:* If a patient opts out of the Health Information System (HIS), personal health information should continue to be received by the HIS from the entity, but patient identifiers must be anonymized in accordance with UAE Federal Law No. (45) of 2021 and the Policy for Health Data Protection and Confidentiality. [dha-consent-access-standard-2025#0018]
- *requirement:* Personal health information should not be retrieved using 'Break the Glass' (BTG) access after a patient has opted out of the HIS. [dha-consent-access-standard-2025#0018]
- *gap (no_provision_found):* **Applicability of Opt-Out to Abu Dhabi (Malaffi)**: The provided texts for Abu Dhabi (DoH Policy on the Abu Dhabi Health Information Exchange) emphasize mandatory participation and sharing of patient data, including instances where patient consent is unavailable. No specific provision was found in the provided knowledge base detailing a patient's right to 'opt-out' of the Malaffi exchange in a manner equivalent to the Dubai NABIDH opt-out process. [doh-hie-policy-2020#0021, doh-hie-policy-2020#0022]
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): DoH Policy on the Abu Dhabi Health Information Exchange (April 2020), p.17 [doh-hie-policy-2020#0018]
- ⚠ Sent back once: only 1 search(es) before answering

## Event 5: Emergency: clinician at Hospital A requests Hospital B's medication list
*2026-11-08T02:30*

Fatima arrives unconscious at Hospital A with bleeding. The doctor needs her full medication list, including Hospital B's, and requests break-the-glass access. She has opted out of NABIDH.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| consent | ED_btg_B_meds | {'allowed': False, 'reason_code': 'EMERGENCY_BLOCKED_BY_OPT_OUT', 'escalate': True} | {'allowed': False, 'reason_code': 'EMERGENCY_BLOCKED_BY_OPT_OUT', 'escalate': True} | **pass** |
| policy | cites uae-health-ict-law-2019 ('health and safety of the patient') | cited | not cited | **fail** |
| policy | cites dha-consent-access-standard-2025 ('should not be retrieved using BTG') | cited | ['dha-consent-access-standard-2025#0018'] | **pass** |
| policy | cites dha-consent-access-standard-2025 ('emergency condition') | cited | not cited | **fail** |
| policy | cites dha-consent-access-standard-2025 ('Emirate of Dubai') | cited | not cited | **fail** |
| policy | expectation for human review | Federal Art. 16(3) health-and-safety exception conflicts with DHA 9.7 opt-out rule. | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | The system must escalate to a human and must not silently override either rule. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CROSS-EMIRATE-EMERGENCY-ACCESS: hypothesis | DHA's break-the-glass rules cover Dubai entities and bar BTG retrieval for opted-out patients (s9.7), while fe | likely match: 'Cross-emirate emergency access procedures' (scope_unclear) | **review** |
| audit | audit trail has 'access_decision' | present | present | **pass** |

**Escalated to a human:** Emergency access was not granted because the patient opted out of NABIDH. A human decision is required.

**Policy agent** (3 searches, completed=True)
- *requirement:* Under Dubai Health Authority (DHA) standards (DHA/HISHD/ST-09), Personal Health Information (PHI) of a patient who has opted out of the Health Information System (HIS) must not be retrieved using Break-the-Glass (BTG) access. [dha-consent-access-standard-2025#0018]
- *requirement:* Under UAE Federal Law (Cabinet Resolution No. 32 of 2020), in an emergency where patient consent cannot be obtained, healthcare providers may examine a patient's file for healthcare purposes, provided they supply reasons for the examination. [uae-health-ict-exec-reg-2020#0007]
- *requirement:* Under the Abu Dhabi Department of Health (DoH) Policy on the Abu Dhabi Health Information Exchange (ADHIE), emergency access ('break the seal') is permitted when a healthcare professional judges that a patient is in immediate need of medical attention and that information accessible via the ADHIE platform may be material to that treatment. [doh-hie-policy-2020#0053, doh-hie-policy-2020#0054]
- *conflict:* There is a potential conflict between the Dubai-specific prohibition on BTG access for opted-out patients and the broader UAE federal provision allowing emergency access to patient files when consent cannot be obtained. The text does not clarify which rule takes precedence in a cross-emirate exchange scenario. [dha-consent-access-standard-2025#0018, uae-health-ict-exec-reg-2020#0007]
- *gap (scope_unclear):* **Cross-emirate emergency access procedures**: The provided texts do not specify the governing rules for emergency access when a clinician in one emirate (Abu Dhabi) requests data from a facility in another emirate (Dubai) where the patient has opted out of the local exchange (NABIDH). It is unclear whether the rules of the requesting facility's jurisdiction, the providing facility's jurisdiction, or a federal standard applies. [dha-consent-access-standard-2025#0018, uae-health-ict-exec-reg-2020#0007, doh-hie-policy-2020#0053]
- ⚠ Sent back once: only 1 search(es) before answering
- ⚠ Repaired citation typo 'dha-hie-policy-2020#0053' -> 'doh-hie-policy-2020#0053' in requirements (retrieved this run)
- ⚠ Repaired citation typo 'dha-hie-policy-2020#0054' -> 'doh-hie-policy-2020#0054' in requirements (retrieved this run)
- ⚠ Repaired citation typo 'dha-hie-policy-2020#0053' -> 'doh-hie-policy-2020#0053' in gap (retrieved this run)

## Event 6: Who owns the follow-up?
*2026-11-08T09:00*

With eGFR 24 and potassium 5.4 on record, Hospital C asks which institution is responsible for coordinating the response across three prescribers in two emirates.

| Area | Check | Expected | Actual | Status |
|---|---|---|---|---|
| safety | finding DEMO-LAB-001:glucophage present | present | present | **pass** |
| safety | finding DEMO-INT-002 absent | absent | absent | **pass** |
| safety | limitation notice mentions HospitalB | present | present | **pass** |
| policy | expectation for human review | If no provision assigning cross-institution responsibility is found in the ingested KB, say so and list what w | see agent output (conflicts, caveats, gaps) | **review** |
| policy | expectation for human review | Absence in the KB is not proof that no rule exists elsewhere. | see agent output (conflicts, caveats, gaps) | **review** |
| gap | GAP-CROSS-INSTITUTION-RESPONSIBILITY: hypothesis | Hypothesis: no ingested provision assigns responsibility for coordinating follow-up on medication findings tha | likely match: 'Responsibility for cross-emirate clinical coordination' (no_provision_found) | **review** |

**Policy agent** (7 searches, completed=True)
- *comparison:* EU regulations (EHDS) require importers of EHR systems to investigate complaints and follow up on information received regarding incidents involving their systems, keeping relevant parties informed. [eu-ehds-2025-327#0128]
- *gap (no_provision_found):* **Responsibility for cross-emirate clinical coordination**: There is no provision in the provided texts that specifies which institution is responsible for coordinating follow-up on high-severity medication findings when the involved prescribers are located in different emirates (e.g., Abu Dhabi and Dubai). []
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): Regulation (EU) 2016/679 (GDPR), Article 75, p.79 [eu-gdpr-2016-679#0200]; DoH Policy on the Abu Dhabi Health Information Exchange (April 2020), p.8 [doh-hie-policy-2020#0007]
- *gap (no_provision_found):* **Impact of patient-withheld data on clinical responsibility**: There is no provision in the provided texts that defines the shift or limitation of clinical responsibility when a patient chooses to withhold data from a safety assessment, rendering it incomplete. []
  - ⚠ passages the agent did not retrieve that may bear on this gap (verify before accepting it): Policy for Health Information Sharing (2024), p.3 [dha-health-info-sharing-2024#0004]; Regulation (EU) 2025/327 on the European Health Data Space, Preamble (part 10), p.1 [eu-ehds-2025-327#0010]; Regulation (EU) 2025/327 on the European Health Data Space, Preamble (part 39), p.1 [eu-ehds-2025-327#0039]
- ⚠ Sent back once: only 3 search(es) before answering
